Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2021.765067
Abstract: Context Glucocorticoid excess exhibits multiple detrimental effects by its catabolic properties. Metformin was recently suggested to protect from adverse metabolic side-effects of glucocorticoid treatment. Whether metformin is beneficial in patients with endogenous glucocorticoid excess has… read more here.
Keywords: treatment; time diagnosis; endogenous glucocorticoid; bone metabolism ... See more keywords